{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:05:11Z","timestamp":1790759111090,"version":"4.1.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:00:00Z","timestamp":1608076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Reumatikerf\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Extracellular HMGB1 acts as an alarmin in multiple autoimmune diseases. While its release and functions have been extensively studied, there is a substantial lack of knowledge regarding HMGB1 regulation at the site of inflammation. Herein we show that enzymes present in arthritis-affected joints process HMGB1 into smaller peptides <jats:italic>in vitro<\/jats:italic>. Gel electrophoresis, Western blotting and mass spectrometry analyses indicate cleavage sites for human neutrophil elastase, cathepsin G, and matrix metalloproteinase 3 within the HMGB1 structure. While human neutrophil elastase and matrix metalloproteinase 3 might alter the affinity of HMGB1 to its receptors by cleaving the acidic C-terminal tail, cathepsin G rapidly and completely degraded the alarmin. Contrary to a previous report we demonstrate that HMGB1 is not a substrate for dipeptidyl peptidase IV. We also provide novel information regarding the presence of these proteases in synovial fluid of juvenile idiopathic arthritis patients. Correlation analysis of protease levels and HMGB1 levels in synovial fluid samples did not, however, reveal any direct relationship between the recorded levels. This study provides knowledge of proteolytic processing of HMGB1 relevant for the regulation of HMGB1 during inflammatory disease.<\/jats:p>","DOI":"10.3389\/fimmu.2020.448262","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T10:25:27Z","timestamp":1610274327000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Cleavage of HMGB1 by Proteolytic Enzymes Associated with Inflammatory Conditions"],"prefix":"10.3389","volume":"11","author":[{"given":"Agnieszka","family":"Sowinska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlin","family":"Rensing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Klevenvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Neog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lundb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Erlandsson","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-030409-101323","article-title":"HMGB1 is a therapeutic target for sterile inflammation and infection","volume":"29","author":"Andersson","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2018.02.011","article-title":"High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells","volume":"38","author":"Andersson","year":"2018","journal-title":"Semin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/art.11028","article-title":"High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis","volume":"48","author":"Pullerits","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/art.11161","article-title":"Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity","volume":"48","author":"Kokkola","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/art.27590","article-title":"Protective targeting of high mobility group box chromosomal protein 1 in a spontaneous arthritis model","volume":"62","author":"Ostberg","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2010.00264","article-title":"Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models","volume":"17","author":"Schierbeck","year":"2011","journal-title":"Mol Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2018.1439924","article-title":"Extracellular HMGB1 as a therapeutic target in inflammatory diseases","volume":"22","author":"Andersson","year":"2018","journal-title":"Expert Opin Ther Targ"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20120189","article-title":"Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release","volume":"209","author":"Venereau","year":"2012","journal-title":"J Exp Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2016.08.018","article-title":"The HMGB1 C-Terminal Tail Regulates DNA Bending","volume":"428","author":"Blair","year":"2016","journal-title":"J Mol Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1021\/bi049364k","article-title":"The long acidic tail of high mobility group box 1 (HMGB1) protein forms an extended and flexible structure that interacts with specific residues within and between the HMG boxes","volume":"43","author":"Knapp","year":"2004","journal-title":"Biochemistry"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2010.07.045","article-title":"Tail-mediated collapse of HMGB1 is dynamic and occurs via differential binding of the acidic tail to the A and B domains","volume":"403","author":"Stott","year":"2010","journal-title":"J Mol Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1003893107","article-title":"A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release","volume":"107","author":"Yang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1073\/pnas.2434651100","article-title":"Reversing established sepsis with antagonists of endogenous high-mobility group box 1","volume":"101","author":"Yang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s10020-019-0081-6","article-title":"Inhibition of HMGB1\/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation","volume":"25","author":"Yang","year":"2019","journal-title":"Mol Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-200208000-00004","article-title":"High mobility group box chromosomal protein 1 (HMGB1) is an antibacterial factor produced by the human adenoid","volume":"52","author":"Zetterstrom","year":"2002","journal-title":"Pediatr Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0908548","article-title":"The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation","volume":"86","author":"Hreggvidsdottir","year":"2009","journal-title":"J Leukocyte Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/joim.12619","article-title":"The haptoglobin beta subunit sequesters HMGB1 toxicity in sterile and infectious inflammation","volume":"282","author":"Yang","year":"2017","journal-title":"J Internal Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI22782","article-title":"The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism","volume":"115","author":"Abeyama","year":"2005","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0b013e3181b0ef7b","article-title":"In vivo and in vitro effects of the anticoagulant, thrombomodulin, on the inflammatory response in rodent models","volume":"33","author":"Hagiwara","year":"2010","journal-title":"Shock"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02033.x","article-title":"The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis","volume":"4","author":"Van de Wouwer","year":"2006","journal-title":"J Thromb Haemostasis JTH"},{"key":"B21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s10020-018-0021-x","article-title":"Ligation of free HMGB1 to TLR2 in the absence of ligand is negatively regulated by the C-terminal tail domain","volume":"24","author":"Aucott","year":"2018","journal-title":"Mol Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.541474","article-title":"An immunogenic peptide in the A-box of HMGB1 protein reverses apoptosis-induced tolerance through RAGE receptor","volume":"289","author":"LeBlanc","year":"2014","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e50300","DOI":"10.1371\/journal.pone.0050300","article-title":"PROSPER: an integrated feature-based tool for predicting protease substrate cleavage sites","volume":"7","author":"Song","year":"2012","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20052203","article-title":"Role of HMGB1 in apoptosis-mediated sepsis lethality","volume":"203","author":"Qin","year":"2006","journal-title":"J Exp Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-8770com","article-title":"Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats","volume":"21","author":"Liu","year":"2007","journal-title":"FASEB J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2213-6","article-title":"High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV","volume":"55","author":"Marchetti","year":"2012","journal-title":"Diabetologia"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1408","article-title":"Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites","volume":"26","author":"Schilling","year":"2008","journal-title":"Nat Biotechnol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/90273","article-title":"Determination of protease cleavage site motifs using mixture-based oriented peptide libraries","volume":"19","author":"Turk","year":"2001","journal-title":"Nat Biotechnol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1124\/pr.110.002733","article-title":"Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases","volume":"62","author":"Korkmaz","year":"2010","journal-title":"Pharmacol Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02387","article-title":"Extended Cleavage Specificity of Human Neutrophil Elastase, Human Proteinase 3, and Their Distant Ortholog Clawed Frog PR3-Three Elastases With Similar Primary but Different Extended Specificities and Stability","volume":"9","author":"Fu","year":"2018","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120987","article-title":"HMGB1 levels are increased in patients with juvenile idiopathic arthritis, correlate with early onset of disease, and are independent of disease duration","volume":"40","author":"Schierbeck","year":"2013","journal-title":"J\u00a0Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.08.017","article-title":"High mobility group box protein 1-A prognostic marker for structural joint damage in 10-year follow-up of patients with juvenile idiopathic arthritis","volume":"46","author":"Pullerits","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/35.6.1016","article-title":"Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in synovial fluid from patients with rheumatoid arthritis and osteoarthritis","volume":"35","author":"Gotoh","year":"1989","journal-title":"Clin Chem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.09.076","article-title":"HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to Allodynia","volume":"17","author":"Das","year":"2016","journal-title":"Cell Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1115884109","article-title":"IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G","volume":"109","author":"Lefrancais","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(87)81162-6","article-title":"The covalent and non-covalent binding modes of elastase with alpha 2-macroglobulin influence the conformation of the protease","volume":"225","author":"Dexpert","year":"1987","journal-title":"FEBS Lett"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.448262\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T10:25:31Z","timestamp":1610274331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.448262\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,16]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2020.448262"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.448262","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,16]]},"article-number":"448262"}}